This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McPherson, R. Search for Related Content PubMed Articles by McPherson, R. Related Collections Risk Factors Acute myocardial infarction Chronic ischemic heart disease Genetics of cardiovascular disease Lipid and lipoprotein metabolism Related Article

Editorials

A Gene-Centric Approach to Elucidating Cardiovascular Risk

Ruth McPherson, MD, PhD, FRCPC

From the Department of Medicine, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.

Correspondence to Ruth McPherson, Department of Medicine, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street H441, Ottawa, Ontario, Canada K1Y 4W7. E-mail: rmcpherson@ottawaheart.ca

Key Words: apolipoproteins • coronary disease • genetics • lipoproteins

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Although behavioral precedents including diet and cigarette smoking play an important role, coronary artery disease (CAD) exhibits significant heritability,¹ a part of which can be attributable to genetic variants affecting known biochemical and metabolic risk factors. In the last 2 years, impressive progress has been made in understanding the genetic basis of several of these using both candidate gene and genome-wide association study (GWAS) approaches.

Article see p 16

Candidate genes, coding for proteins of known biological significance in a disease process, provide a logical first step in understanding the genetics of common disease states. Populations of affected and unaffected individuals can be studied by genotyping common single-nucleotide polymorphisms (SNPs) within a gene and its regulatory sequences. Although economically attractive, this approach is acknowledged to have a number of limitations. By definition, studies are limited to genes with a known or suspected role in defining a given phenotype and do not provide new insight into biological pathways leading to disease. Furthermore, candidate gene associations often fail to replicate for multiple reasons. Sample sizes have often been inadequate to provide the statistical power required when multiple variants of small effect are tested. The original observation may have been false positive, emphasizing the need for stringent statistical thresholds. Other issues include heterogeneity of causality. For example, genetic variants affecting plasma lipid traits may have significant effects on CAD risk, but these may be less important than or interact with other risk factors including diabetes and smoking. Finally, appropriate measures must be taken . . . [Full Text of this Article]

Related Article

Genetic Variants Associated With Myocardial Infarction Risk Factors in Over 8000 Individuals From Five Ethnic Groups: The INTERHEART Genetics Study

Sonia S. Anand, Changchun Xie, Guillaume Paré, Alexandre Montpetit, Sumathy Rangarajan, Matthew J. McQueen, Heather J. Cordell, Bernard Keavney, Salim Yusuf, Thomas J. Hudson, James C. Engert on Behalf of the INTERHEART Investigators
Circ Cardiovasc Genet 2009 2: 16-25. [Abstract] [Full Text] [PDF]